BioSpace News Archive

Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies, today announced that it has acquired Canton, Mass.-based Chemic Laboratories, Inc. (Chemic)

The market is estimated to grow with a CAGR of 7.9% from 2018-2025.

The global advanced medical stopcock market is expected to reach US$ 1,167.6 Mn in 2027 from US$ 841.3 Mn in 2018.

The global embolization coils market is expected to reach US$ 1,131.24 Mn in 2025 from US$ 784.60 Mn in 2017.

The report highlights the trends prevailing in the global wearable injectors market, and drivers and deterrents pertaining to its growth.

The genetic test, a first of its kind, identifies specific DNA biomarkers in order to gauge the risk and potential of adverse reactions toward hallucinogenic drugs.

In recent years, methamphetamine use and related harms have increased in many communities, especially in Western and Central Canada.

Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced a partnership with University of California, San Francisco to develop non-invasive, individualized, peripheral nerve stimulation therapies that leverage Cala Health’s neuromodulation and data science platform technology.

A novel synthetic opioid with purported potency greater than fentanyl has emerged in the United States and is linked to a growing number of overdose deaths across at least five states.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the Raymond James 2021 Human Health Innovation Conference